Trials / Completed
CompletedNCT05130671
Nutritional Supplementation of Flavonoids Quercetin and Curcumin for Early Mild Symptoms of COVID-19
Treatment Benefits of Flavonoids Quercetin and Curcumin Supplements for Mild Symptoms of COVID-19
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- King Edward Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the therapeutic benefits of flavonoids nutritional supplements quercetin and curcumin for early mild symptoms of COVID-19.
Detailed description
Flavonoids nutritional supplements quercetin and curcumin have demonstrated strong antioxidant, broad-spectrum anti-viral and anti-inflammatory properties including against the respiratory tract infections. They are widely used to boost the immunity against infections and keeping healthy life-style. Results from recent published studies have shown positive results for quercetin and curcumin in patients with COVID-19. In the present study the investigators aim to study the combined beneficial effects of quercetin and curcumin in addition to standard of care for managing early mild symptoms of COVID-19 in community-based patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Standard of care | Standard of care treatment as per the hospital guidelines |
| DIETARY_SUPPLEMENT | Investigational treatment | Combination of quercetin and curcumin as add-on to the standard of care |
Timeline
- Start date
- 2021-10-25
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
- First posted
- 2021-11-23
- Last updated
- 2022-01-28
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT05130671. Inclusion in this directory is not an endorsement.